mlive.com — The colon cancer research study Dr. Larry McCahill undertook had a few factors working against it. It lacked the razzle-dazzle appeal of a new drug - not to mention the promotional push of a major drug company. And enrolling patients in the clinical trial moved slowly because they had to meet extremely specific criteria.